Company / Operating Income per Share
Xenetic Biosciences, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.73
FY2025
5-year range
-$4.43 / -$0.43
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-10.34 in FY2017 to $-0.41 in FY2018.
Based on SEC 10-K filings.
-2.73 in FY2025.
Improved from $-4.43 to $-2.73 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 7.0% year-over-year.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.73 | +7.0% |
| FY2024 | -$2.93 | +33.8% |
| FY2023 | -$4.43 | -935.9% |
| FY2022 | -$0.43 | +73.2% |
| FY2021 | -$1.59 | +25.0% |
| FY2020 | -$2.12 | -77.1% |
| FY2019 | -$1.20 | -193.0% |
| FY2018 | -$0.41 | +96.0% |
| FY2017 | -$10.34 | -382.9% |
| FY2016 | -$2.14 | -2904.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026